{
    "title": "115_hr1318",
    "content": "SECTION 1. SHORT TITLE.\n    This Act may be cited as the ``Preventing Maternal Deaths Act of \n2018''.\nSEC. 2. SAFE MOTHERHOOD.\n    Section 317K of the Public Health Service Act (42 U.S.C. 247b-12) \nis amended--\n        (1) in subsection (a)--\n            (A) in paragraph (1)--\n                (i) by striking ``purpose of this subsection is to \n            develop'' and inserting ``purposes of this subsection are \n            to establish or continue a Federal initiative to support \n            State and tribal maternal mortality review committees, to \n            improve data collection and reporting around maternal \n            mortality, and to develop or support'';\n                (ii) by striking ``population at risk of death and'' \n            and inserting ``populations at risk of death and severe''; \n            and\n            (B) in paragraph (2)--\n                (i) by amending subparagraph (A) to read as follows:\n            ``(A) The Secretary may continue and improve activities \n        related to a national maternal mortality data collection and \n        surveillance program to identify and support the review of \n        pregnancy-associated deaths and pregnancy-related deaths that \n        occur during, or within 1 year following, pregnancy.''; and\n                (ii) by inserting after subparagraph (C) the following:\n            ``(D) The Secretary may, in cooperation with States, Indian \n        tribes, and tribal organizations, develop a program to support \n        States, Indian tribes, and tribal organizations in establishing \n        or operating maternal mortality review committees, in \n        accordance with subsection (d).'';\n        (2) in subsection (b)(2)--\n            (A) in subparagraph (A)--\n                (i) by striking ``encouraging preconception'' and \n            inserting ``prepregnancy''; and\n                (ii) by striking ``diabetics'' and inserting ``women \n            with diabetes and women with substance use disorder'' \n            before the semicolon;\n            (B) in subparagraph (H)--\n                (i) by inserting ``the identification of the \n            determinants of disparities in maternal care, health risks, \n            and health outcomes, including'' before ``an examination''; \n            and\n                (ii) by inserting ``and other groups of women with \n            disproportionately high rates of maternal mortality'' \n            before the semicolon;\n            (C) in subparagraph (I), by striking ``domestic'' and \n        inserting ``interpersonal'';\n            (D) by redesignating subparagraphs (I) through (L) as \n        subparagraphs (J) through (M), respectively;\n            (E) by inserting after subparagraph (H) the following:\n            ``(I) activities to reduce disparities in maternity \n        services and outcomes;''; and\n            (F) in subparagraph (K), as so redesignated, by striking \n        ``, alcohol and illegal drug use'' and inserting ``and \n        substance abuse and misuse'';\n        (3) in subsection (c)--\n            (A) by striking ``(1) In general--The Secretary'' and \n        inserting ``The Secretary'';\n            (B) by redesignating subparagraphs (A) through (C) as \n        paragraphs (1) through (3), respectively, and adjusting the \n        margins accordingly;\n            (C) in paragraph (1), as so redesignated, by striking ``and \n        the building of partnerships with outside organizations \n        concerned about safe motherhood'';\n            (D) in paragraph (2), as so redesignated, by striking ``; \n        and'' and inserting a semicolon;\n            (E) in paragraph (3), as so redesignated, by striking the \n        period and inserting ``; and''; and\n            (F) by adding at the end the following:\n        ``(4) activities to promote physical, mental, and behavioral \n    health during, and up to 1 year following, pregnancy, with an \n    emphasis on prevention of, and treatment for, mental health \n    disorders and substance use disorder.'';\n        (4) by redesignating subsection (d) as subsection (f);\n        (5) by inserting after subsection (c) the following:\n    ``(d) Maternal Mortality Review Committees.--\n        ``(1) In general.--In order to participate in the program under \n    subsection (a)(2)(D), the applicable maternal mortality review \n    committee of the State, Indian tribe, or tribal organization \n    shall--\n            ``(A) include multidisciplinary and diverse membership that \n        represents a variety of clinical specialties, State, tribal, or \n        local public health officials, epidemiologists, statisticians, \n        community organizations, geographic regions within the area \n        covered by such committee, and individuals or organizations \n        that represent the populations in the area covered by such \n        committee that are most affected by pregnancy-related deaths or \n        pregnancy-associated deaths and lack of access to maternal \n        health care services; and\n            ``(B) demonstrate to the Centers for Disease Control and \n        Prevention that such maternal mortality review committee's \n        methods and processes for data collection and review, as \n        required under paragraph (3), use best practices to reliably \n        determine and include all pregnancy-associated deaths and \n        pregnancy-related deaths, regardless of the outcome of the \n        pregnancy.\n        ``(2) Process for confidential reporting.--States, Indian \n    tribes, and tribal organizations that participate in the program \n    described in this subsection shall, through the State maternal \n    mortality review committee, develop a process that--\n            ``(A) provides for confidential case reporting of \n        pregnancy-associated and pregnancy-related deaths to the \n        appropriate State or tribal health agency, including such \n        reporting by--\n                ``(i) health care professionals;\n                ``(ii) health care facilities;\n                ``(iii) any individual responsible for completing death \n            records, including medical examiners and medical coroners; \n            and\n                ``(iv) other appropriate individuals or entities; and\n            ``(B) provides for voluntary and confidential case \n        reporting of pregnancy-associated deaths and pregnancy-related \n        deaths to the appropriate State or tribal health agency by \n        family members of the deceased, and other appropriate \n        individuals, for purposes of review by the applicable maternal \n        mortality review committee; and\n            ``(C) shall include--\n                ``(i) making publicly available contact information of \n            the committee for use in such reporting; and\n                ``(ii) conducting outreach to local professional \n            organizations, community organizations, and social services \n            agencies regarding the availability of the review \n            committee.\n        ``(3) Data collection and review.--States, Indian tribes, and \n    tribal organizations that participate in the program described in \n    this subsection shall--\n            ``(A) annually identify pregnancy-associated deaths and \n        pregnancy-related deaths--\n                ``(i) through the appropriate vital statistics unit \n            by--\n\n                    ``(I) matching each death record related to a \n                pregnancy-associated death or pregnancy-related death \n                in the State or tribal area in the applicable year to a \n                birth certificate of an infant or fetal death record, \n                as applicable;\n                    ``(II) to the extent practicable, identifying an \n                underlying or contributing cause of each pregnancy-\n                associated death and each pregnancy-related death in \n                the State or tribal area in the applicable year; and\n                    ``(III) collecting data from medical examiner and \n                coroner reports, as appropriate;\n\n                ``(ii) using other appropriate methods or information \n            to identify pregnancy-associated deaths and pregnancy-\n            related deaths, including deaths from pregnancy outcomes \n            not identified through clause (i)(I);\n            ``(B) through the maternal mortality review committee, \n        review data and information to identify adverse outcomes that \n        may contribute to pregnancy-associated death and pregnancy-\n        related death, and to identify trends, patterns, and \n        disparities in such adverse outcomes to allow the State, Indian \n        tribe, or tribal organization to make recommendations to \n        individuals and entities described in paragraph (2)(A), as \n        appropriate, to improve maternal care and reduce pregnancy-\n        associated death and pregnancy-related death;\n            ``(C) identify training available to the individuals and \n        entities described in paragraph (2)(A) for accurate \n        identification and reporting of pregnancy-associated and \n        pregnancy-related deaths;\n            ``(D) ensure that, to the extent practicable, the data \n        collected and reported under this paragraph is in a format that \n        allows for analysis by the Centers for Disease Control and \n        Prevention; and\n            ``(E) publicly identify the methods used to identify \n        pregnancy-associated deaths and pregnancy-related deaths in \n        accordance with this section.\n        ``(4) Confidentiality.--States, Indian tribes, and tribal \n    organizations participating in the program described in this \n    subsection shall establish confidentiality protections to ensure, \n    at a minimum, that--\n            ``(A) there is no disclosure by the maternal mortality \n        review committee, including any individual members of the \n        committee, to any person, including any government official, of \n        any identifying information about any specific maternal \n        mortality case; and\n            ``(B) no information from committee proceedings, including \n        deliberation or records, is made public unless specifically \n        authorized under State and Federal law.\n        ``(5) Reports to cdc.--For fiscal year 2019, and each \n    subsequent fiscal year, each maternal mortality review committee \n    participating in the program described in this subsection shall \n    submit to the Director of the Centers for Disease Control and \n    Prevention a report that includes--\n            ``(A) data, findings, and any recommendations of such \n        committee; and\n            ``(B) as applicable, information on the implementation \n        during such year of any recommendations submitted by the \n        committee in a previous year.\n        ``(6) State partnerships.--States may partner with one or more \n    neighboring States to carry out the activities under this \n    subparagraph. With respect to the States in such a partnership, any \n    requirement under this subparagraph relating to the reporting of \n    information related to such activities shall be deemed to be \n    fulfilled by each such State if a single such report is submitted \n    for the partnership.\n        ``(7) Appropriate mechanisms for indian tribes and tribal \n    organizations.--The Secretary, in consultation with Indian tribes, \n    shall identify and establish appropriate mechanisms for Indian \n    tribes and tribal organizations to demonstrate, report data, and \n    conduct the activities as required for participation in the program \n    described in this subsection. Such mechanisms may include technical \n    assistance with respect to grant application and submission \n    procedures, and award management activities.\n        ``(8) Research availability.--The Secretary shall develop a \n    process to ensure that data collected under paragraph (5) is made \n    available, as appropriate and practicable, for research purposes, \n    in a manner that protects individually identifiable or potentially \n    identifiable information and that is consistent with State and \n    Federal privacy law.\n    ``(e) Definitions.--In this section--\n        ``(1) the terms `Indian tribe' and `tribal organization' have \n    the meanings given such terms in section 4 of the Indian Self-\n    Determination and Education Assistance Act;\n        ``(2) the term `pregnancy-associated death' means a death of a \n    woman, by any cause, that occurs during, or within 1 year \n    following, her pregnancy, regardless of the outcome, duration, or \n    site of the pregnancy; and\n        ``(3) the term `pregnancy-related death' means a death of a \n    woman that occurs during, or within 1 year following, her \n    pregnancy, regardless of the outcome, duration, or site of the \n    pregnancy--\n            ``(A) from any cause related to, or aggravated by, the \n        pregnancy or its management; and\n            ``(B) not from accidental or incidental causes.''; and\n        (6) in subsection (f), as so redesignated, by striking ``such \n    sums as may be necessary for each of the fiscal years 2001 through \n    2005'' and inserting ``$58,000,000 for each of fiscal years 2019 \n    through 2023''.\n\n                               Speaker of the House of Representatives.\n\n                            Vice President of the United States and    \n                                               President of the Senate."
}